We are live on ! Find out more
TECH icon

Bio-Techne

355 hedge funds and large institutions have $7.06B invested in Bio-Techne in 2019 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 127 increasing their positions, 110 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

133% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 24

38% more capital invested

Capital invested by funds: $5.12B → $7.06B (+$1.94B)

15% more repeat investments, than reductions

Existing positions increased: 127 | Existing positions reduced: 110

9% more funds holding

Funds holding: 327355 (+28)

0.05% less ownership

Funds ownership: 376.56%376.51% (-0.05%)

34% less call options, than puts

Call options by funds: $2.94M | Put options by funds: $4.47M

Holders
355
Holders Change
+28
Holders Change %
+8.56%
% of All Funds
7.68%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
56
Increased
127
Reduced
110
Closed
24
Calls
$2.94M
Puts
$4.47M
Net Calls
-$1.53M
Net Calls Change
-$2.27M
Name Holding Trade Value Shares
Change
Change in
Stake
TPSF
101
Texas Permanent School Fund
Texas
$5.09M +$167K +3,716 +4%
TRSOTSOK
102
Teachers Retirement System of the State of Kentucky
Kentucky
$4.93M
GC
103
Guggenheim Capital
Illinois
$4.91M -$200K -4,440 -4%
RJA
104
Raymond James & Associates
Florida
$4.73M -$144K -3,196 -3%
MIP
105
Mondrian Investment Partners
United Kingdom
$4.58M
WRF
106
Waddell & Reed Financial
Kansas
$4.57M +$4.15M +92,116 New
MIM
107
MetLife Investment Management
New Jersey
$4.57M -$1.26K -28 -0%
Canada Life
108
Canada Life
Manitoba, Canada
$4.56M -$38.7K -860 -0.9%
Prudential Financial
109
Prudential Financial
New Jersey
$4.45M -$39.6K -880 -1%
TCM
110
Tekla Capital Management
Massachusetts
$4.31M +$3.91M +86,804 New
Allianz Asset Management
111
Allianz Asset Management
Germany
$4.31M -$681K -15,128 -15%
EVM
112
Eaton Vance Management
Massachusetts
$4.16M
Baird Financial Group
113
Baird Financial Group
Wisconsin
$4.13M +$3.08M +68,516 +467%
Envestnet Asset Management
114
Envestnet Asset Management
Illinois
$4.11M +$518K +11,520 +16%
State of Tennessee, Department of Treasury
115
State of Tennessee, Department of Treasury
Tennessee
$4.01M +$1.8M +40,000 +98%
MSA
116
Mason Street Advisors
Wisconsin
$3.99M +$54.2K +1,204 +2%
T. Rowe Price Associates
117
T. Rowe Price Associates
Maryland
$3.89M +$215K +4,768 +6%
OAM
118
Oppenheimer Asset Management
New York
$3.77M +$127K +2,828 +4%
Nisa Investment Advisors
119
Nisa Investment Advisors
Missouri
$3.6M +$18K +400 +0.6%
MPAM
120
Murphy Pohlad Asset Management
Minnesota
$3.55M +$3.22M +71,600 New
LIM
121
Leavell Investment Management
Alabama
$3.54M
ProShare Advisors
122
ProShare Advisors
Maryland
$3.47M +$189K +4,200 +6%
USAA
123
United Services Automobile Association
Texas
$3.45M +$1.68M +37,324 +116%
RP
124
Rowlandmiller & Partners
Georgia
$3.39M -$5.94K -132 -0.2%
AG
125
Aperio Group
California
$3.25M -$541K -12,016 -16%

TECH Hedge Fund Activity: Q1 2019 in Review

355 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2019, worth a combined $7.06B — up 38% from $5.12B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new TECH positions and 24 closed out — a net gain of 32 holders — while 127 added to existing stakes and 110 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $46.2M. The largest seller was AQR Capital Management, cutting an estimated $30.7M.

  • 355 institutional investors held Bio-Techne (TECH) as of Q1 2019, up from 327 in Q4 2018.
  • Funds reported $7.06B of Bio-Techne stock for Q1 2019, up 38% quarter-over-quarter.
  • 56 funds opened new Bio-Techne positions in Q1 2019 and 24 closed out, a net change of +32 holders.
  • The largest Bio-Techne buyer in Q1 2019 was Wellington Management Group, an estimated $46.2M added.
  • The largest Bio-Techne seller in Q1 2019 was AQR Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q1 2019.